UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.515

Sortiert nach

The influences of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of simvastatin, in relation to CYP3A4 inhibition

Pharmacogenomics, 2017-04, Vol.18 (5), p.459-469

2017

Volltextzugriff (PDF)

Current globalization of drug interventional clinical trials: characteristics and associated factors, 2011-2013

Trials, 2017-06, Vol.18 (1), p.288-8, Article 288

2017

Volltextzugriff (PDF)

Effects of the CYP2D610 allele on the pharmacokinetics of atomoxetine and its metabolites

Archives of Pharmacal Research, 2015, 38(11), , pp.2083-2091

2015

Volltextzugriff (PDF)

Functional Characterization of Allelic Variants of Polymorphic Human Cytochrome P450 2A6 (CYP2A65, 7, 8, 18, 19, and 35)

Biological and Pharmaceutical Bulletin, 2012/03/01, Vol.35(3), pp.394-399

2012

Volltextzugriff (PDF)

Expression efficiency of NAT2 haplotypes in a Korean population

Genes & Genetic Systems, 2016/10/01, Vol.91(5), pp.277-281

2016

Volltextzugriff (PDF)

Construction of a database for published phase II/III drug intervention clinical trials for the period 2009-2014 comprising 2,326 records, 90 disease categories, and 939 drug entities

International journal of clinical pharmacology and therapeutics, 2016-06, Vol.54 (6), p.416

2016

Volltextzugriff (PDF)

Screening of genetic variations of SLC15A2, SLC22A1, SLC22A2 and SLC22A6 genes

Journal of human genetics, 2011-09, Vol.56 (9), p.666-670

2011

Volltextzugriff (PDF)

The influences of CYP2D6 genotypes and drug interactions on the pharmacokinetics of venlafaxine: exploring predictive biomarkers for treatment outcomes

Psychopharmacology, 2015-06, Vol.232 (11), p.1899-1909

2015

Volltextzugriff (PDF)

Determination of zolpidem in human plasma by liquid chromatography–tandem mass spectrometry for clinical application

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2015-04, Vol.986-987, p.129-134

2015

Volltextzugriff (PDF)

Toxicometabolomics approach to urinary biomarkers for mercuric chloride (HgCl 2)-induced nephrotoxicity using proton nuclear magnetic resonance ( 1H NMR) in rats

Toxicology and applied pharmacology, 2010-12, Vol.249 (2), p.114-126

2010

Volltextzugriff (PDF)

Usefulness of Heavy Drinking and Binge Drinking for the Diagnosis of Alcohol Use Disorder

Korean Journal of Family Medicine, 2016, 37(4), , pp.214-220

2016

Volltextzugriff (PDF)

Frequency of CYP2C9 alleles in Koreans and their effects on losartan pharmacokinetics

Acta pharmacologica Sinica, 2011-10, Vol.32 (10), p.1303-1308

2011

Volltextzugriff (PDF)

Diabetes and depressive symptoms in korean women: the fifth korean national health and nutrition examination survey (2010-2011)

Korean Journal of Family Medicine, 2014, 35(3), , pp.127-135

2014

Volltextzugriff (PDF)

Exposure-outcome analysis in depressed patients treated with paroxetine using population pharmacokinetics

Drug design, development and therapy, 2015-01, Vol.9 (default), p.5247-5254

2015

Volltextzugriff (PDF)

Functional Study of Haplotypes in UGT1A1 Promoter to Find a Novel Genetic Variant Leading to Reduced Gene Expression

Therapeutic drug monitoring, 2015-06, Vol.37 (3), p.369

2015

Volltextzugriff (PDF)

Expression of CYP2A6, CYP2D6 and CYP4A11 Polymorphisms in COS7 Mammalian Cell Line

한국독성학회지, 2011, 27(1), , pp.25-29

2011

Volltextzugriff (PDF)

Effects of CYP2C19 Genetic Polymorphisms on PK/PD Responses of Omeprazole in Korean Healthy Volunteers

Journal of Korean Medical Science, 2017, 32(5), 227, pp.729-736

2017

Volltextzugriff (PDF)

Comparison of genetic variations of the SLCO1B1 , SLCO1B3 , and SLCO2B1 genes among five ethnic groups

Environmental toxicology and pharmacology, 2015-11, Vol.40 (3), p.692-697

2015

Volltextzugriff (PDF)

The influences of

Pharmacogenomics, 2017-04, Vol.18 (5), p.459-469

2017

Volltextzugriff (PDF)

Determination of DPYD enzyme activity in Korean population

Therapeutic drug monitoring, 2015-04, Vol.37 (2), p.147

2015

Volltextzugriff (PDF)

Direct sequencing and comprehensive screening of genetic polymorphisms on CYP2 family genes (CYP2A6, CYP2B6, CYP2C8, and CYP2E1) in five ethnic populations

Archives of Pharmacal Research, 2015, 38(1), , pp.115-128

2015

Volltextzugriff (PDF)

Direct sequencing for comprehensive screening of LDLR genetic polymorphisms among five ethnic populations Jeong-Hyun

Genes & genomics, 2015-03, Vol.37 (3), p.247-255

2015

Volltextzugriff (PDF)

Direct sequencing for comprehensive screening of LDLR genetic polymorphisms among five ethnic populations

Genes & Genomics, 2015, 37(3), , pp.247-255

2015

Volltextzugriff (PDF)

Expression of CYP2A6, CYP2D6 and CYP4A11 Polymorphisms in COS7 Mammalian Cell Line

Toxicological research (Seoul), 2011, Vol.27 (1), p.25-29

2011

Volltextzugriff (PDF)

골관절염의 임상시험평가지침에 관한 연구

臨床藥理學會誌, 2009, Vol.17 (2), p.139-151

2009

Volltextzugriff (PDF)

1 – 25 von 1.515

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.378)
Mit Volltextzugriff
(1.428)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(28)

Menü

Weitere Dienste

Einstellungen

The influences of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of simvastatin, in relation to CYP3A4 inhibition

Current globalization of drug interventional clinical trials: characteristics and associated factors, 2011-2013

Effects of the CYP2D610 allele on the pharmacokinetics of atomoxetine and its metabolites

Functional Characterization of Allelic Variants of Polymorphic Human Cytochrome P450 2A6 (CYP2A65, 7, 8, 18, 19, and 35)

Expression efficiency of NAT2 haplotypes in a Korean population

Construction of a database for published phase II/III drug intervention clinical trials for the period 2009-2014 comprising 2,326 records, 90 disease categories, and 939 drug entities

Screening of genetic variations of SLC15A2, SLC22A1, SLC22A2 and SLC22A6 genes

The influences of CYP2D6 genotypes and drug interactions on the pharmacokinetics of venlafaxine: exploring predictive biomarkers for treatment outcomes

Determination of zolpidem in human plasma by liquid chromatography–tandem mass spectrometry for clinical application

Toxicometabolomics approach to urinary biomarkers for mercuric chloride (HgCl 2)-induced nephrotoxicity using proton nuclear magnetic resonance ( 1H NMR) in rats

Usefulness of Heavy Drinking and Binge Drinking for the Diagnosis of Alcohol Use Disorder

Frequency of CYP2C9 alleles in Koreans and their effects on losartan pharmacokinetics

Diabetes and depressive symptoms in korean women: the fifth korean national health and nutrition examination survey (2010-2011)

Exposure-outcome analysis in depressed patients treated with paroxetine using population pharmacokinetics

Functional Study of Haplotypes in UGT1A1 Promoter to Find a Novel Genetic Variant Leading to Reduced Gene Expression

Expression of CYP2A6, CYP2D6 and CYP4A11 Polymorphisms in COS7 Mammalian Cell Line

Effects of CYP2C19 Genetic Polymorphisms on PK/PD Responses of Omeprazole in Korean Healthy Volunteers

Comparison of genetic variations of the SLCO1B1 , SLCO1B3 , and SLCO2B1 genes among five ethnic groups

The influences of

Determination of DPYD enzyme activity in Korean population

Direct sequencing and comprehensive screening of genetic polymorphisms on CYP2 family genes (CYP2A6, CYP2B6, CYP2C8, and CYP2E1) in five ethnic populations

Direct sequencing for comprehensive screening of LDLR genetic polymorphisms among five ethnic populations Jeong-Hyun

Direct sequencing for comprehensive screening of LDLR genetic polymorphisms among five ethnic populations

Expression of CYP2A6, CYP2D6 and CYP4A11 Polymorphisms in COS7 Mammalian Cell Line

골관절염의 임상시험평가지침에 관한 연구

Suchergebnisse filtern